Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Shore

Showing results (141-150 of 191) with videos related to

Pageof 20
Sort By:
Prostate Cancer and Prostatic Diseases|October 26, 2023
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancerRobert Hugh Jones, Karim Fizazi, Nicholas D James, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2015
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison T Stopeck, Karim Fizazi, Jean-Jacques Body, et al.
The Journal of Urology|August 9, 2023
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancerMatthew D Galsky, Arjun V Balar, Peter C Black, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS TrialMaha Hussain, Bertrand Tombal, Fred Saad, et al.
Clinical Genitourinary Cancer|March 11, 2025
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart ReviewGirish S Kulkarni, Thomas Guzzo, Philip H Abbosh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2015
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Henry G Bone, Richard H de Boer, et al.
The New England Journal of Medicine|September 21, 2020
Survival with Olaparib in Metastatic Castration-Resistant Prostate CancerMaha Hussain, Joaquin Mateo, Karim Fizazi, et al.
The New England Journal of Medicine|April 29, 2020
Olaparib for Metastatic Castration-Resistant Prostate CancerJohann de Bono, Joaquin Mateo, Karim Fizazi, et al.
Pageof 20

Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Prostate Cancer and Prostatic Diseases|October 26, 2023
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancerRobert Hugh Jones, Karim Fizazi, Nicholas D James, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2015
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison T Stopeck, Karim Fizazi, Jean-Jacques Body, et al.
The Journal of Urology|August 9, 2023
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancerMatthew D Galsky, Arjun V Balar, Peter C Black, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS TrialMaha Hussain, Bertrand Tombal, Fred Saad, et al.
Clinical Genitourinary Cancer|March 11, 2025
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart ReviewGirish S Kulkarni, Thomas Guzzo, Philip H Abbosh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2015
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Henry G Bone, Richard H de Boer, et al.
The New England Journal of Medicine|September 21, 2020
Survival with Olaparib in Metastatic Castration-Resistant Prostate CancerMaha Hussain, Joaquin Mateo, Karim Fizazi, et al.
The New England Journal of Medicine|April 29, 2020
Olaparib for Metastatic Castration-Resistant Prostate CancerJohann de Bono, Joaquin Mateo, Karim Fizazi, et al.
Pageof 20